Diaphragmatic Thickening Fraction as a Predictor of Successful Weaning
Launched by MANSOURA UNIVERSITY HOSPITAL · Jun 13, 2024
Trial Information
Current as of November 05, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying whether a specific measurement called the diaphragmatic thickening fraction, which can be seen using an ultrasound, can help predict if patients will be successfully taken off mechanical ventilation. Mechanical ventilation is a method used to help patients breathe when they are unable to do so on their own, often due to severe respiratory problems. The researchers hope that by measuring how well the diaphragm (the main muscle used for breathing) thickens during breathing, they can better determine which patients are ready to stop using the ventilator.
To participate in this trial, individuals must be adults over 18 years old who are currently on mechanical ventilation due to serious breathing issues. However, some people won't be eligible, such as those under 18, pregnant women, or those with certain medical conditions that could interfere with the ultrasound or affect their diaphragm's function. If someone qualifies and decides to join, they can expect to undergo ultrasound exams to measure their diaphragm's function during the study. This research aims to improve the process of safely weaning patients off mechanical ventilation, which can be a critical step in their recovery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult patients \>18 years old, who are in need for mechanical ventilation as: Life threatening hypoxia, Respiratory rate \> 30 breath/min, Disturbed conscious level.
- Exclusion Criteria:
- • Age \<18 years.
- • Pregnancy
- • Surgical incisions likely to interfere with ultrasound examination.
- • Hepato-splenomegaly, Ascites
- • Neuromuscular disease as Myasthenia gravis, kypho-scoliosis
- • Diaphragmatic Paralysis (paralyzed diaphragm exhibiting abnormal paradoxical movement, i.e., moving in a cranial direction during inspiration
About Mansoura University Hospital
Mansoura University Hospital, a leading academic medical institution in Egypt, is dedicated to advancing healthcare through innovative clinical research and high-quality patient care. As a sponsor of clinical trials, the hospital leverages its extensive resources, multidisciplinary expertise, and state-of-the-art facilities to facilitate groundbreaking studies across various medical fields. Committed to ethical standards and regulatory compliance, Mansoura University Hospital aims to contribute to the development of new therapies and improve patient outcomes, while fostering collaboration with researchers, healthcare professionals, and industry partners.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Mansoura, Egypt
Patients applied
Trial Officials
Mohamed AbdElmoniem
Principal Investigator
Mansoura University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported